E-LIB Suche - Ergebnisse für: Becerra, Carlos R.

1

A phase I, open-label study evaluating the safety and pharm..:

Saif, Muhammad Wasif ; Becerra, Carlos R. ; Fakih, Marwan G....
Cancer Chemotherapy and Pharmacology. 88 (2021) 3 - p. 485-497 , 2021

Link: https://doi.org/10.1007/..

2

Author Correction: Targeting LIF-mediated paracrine interac..:

Shi, Yu ; Gao, Weina ; Lytle, Nikki K....
Nature. 600 (2021) 7889 - p. E18-E18 , 2021

Link: https://doi.org/10.1038/..

3

Phase 1 study of MRX34, a liposomal miR-34a mimic, in patie..:

Hong, David S. ; Kang, Yoon-Koo ; Borad, Mitesh...
British Journal of Cancer. 122 (2020) 11 - p. 1630-1637 , 2020

Link: https://doi.org/10.1038/..

4

Targeting LIF-mediated paracrine interaction for pancreatic..:

Shi, Yu ; Gao, Weina ; Lytle, Nikki K....
Nature. 569 (2019) 7754 - p. 131-135 , 2019

Link: https://doi.org/10.1038/..

5

A Phase 1, Open-Label, Randomized, Crossover Study Evaluati..:

Becerra, Carlos R. ; Yoshida, Kenichiro ; Mizuguchi, Hirokazu..
The Journal of Clinical Pharmacology. 57 (2017) 6 - p. 751-759 , 2017

Link: https://doi.org/10.1002/..

6

Patient-reported Symptoms of Tenosynovial Giant Cell Tumors:

Gelhorn, Heather L. ; Tong, Sandra ; McQuarrie, Kelly...
Clinical Therapeutics. 38 (2016) 4 - p. 778-793 , 2016

Link: https://doi.org/10.1016/..

7

An innovative, multi-arm, complete phase 1b study of the no..:

Jotte, Robert M. ; Von Hoff, Daniel D. ; Braiteh, Fadi...
Investigational New Drugs. 33 (2014) 1 - p. 148-158 , 2014

Link: https://doi.org/10.1007/..

8

Phase I study of the MEK inhibitor trametinib in combinatio..:

Tolcher, Anthony W. ; Patnaik, Amita ; Papadopoulos, Kyriakos P....
Cancer Chemotherapy and Pharmacology. 75 (2014) 1 - p. 183-189 , 2014

Link: https://doi.org/10.1007/..

9

Figitumumab in patients with refractory metastatic colorect..:

Becerra, Carlos R. ; Salazar, Ramon ; Garcia-Carbonero, Rocio...
Cancer Chemotherapy and Pharmacology. 73 (2014) 4 - p. 695-702 , 2014

Link: https://doi.org/10.1007/..

10

A phase I dose-escalation study of MEDI-575, a PDGFRα monoc..:

Becerra, Carlos R. ; Conkling, Paul ; Vogelzang, Nicholas...
Cancer Chemotherapy and Pharmacology. 74 (2014) 5 - p. 917-925 , 2014

Link: https://doi.org/10.1007/..

11

Phase 2 trial of afatinib, an ErbB family blocker, in solid..:

Kwak, Eunice L. ; Shapiro, Geoffrey I. ; Cohen, Seth M....
Cancer. 119 (2013) 16 - p. 3043-3051 , 2013

Link: https://doi.org/10.1002/..

12

Adverse Effects of Bevacizumab and Their Management in Soli..:

Arriaga, Yull ; Becerra, Carlos R.
Supportive Cancer Therapy. 3 (2006) 4 - p. 247-250 , 2006

Link: https://doi.org/10.3816/..

13

A phase II clinical and pharmacokinetic study of intravenou..:

Ajani, Jaffer A. ; Takimoto, Chris ; Becerra, Carlos R....
Investigational New Drugs. 23 (2005) 5 - p. 479-484 , 2005

Link: https://doi.org/10.1007/..

14

IκB kinase α regulates subcellular distribution and turnove..:

Kwak, Youn-Tae ; Li, Rui ; Becerra, Carlos R....
Journal of Biological Chemistry. 280 (2005) 46 - p. 38888 , 2005

Link: https://doi.org/10.1016/..

15

IκB Kinase α Regulates Subcellular Distribution and Turnove..:

Kwak, Youn-Tae ; Li, Rui ; Becerra, Carlos R....
Journal of Biological Chemistry. 280 (2005) 40 - p. 33945-33952 , 2005

Link: https://doi.org/10.1074/..